Innoviva
INVA
#5088
Rank
โ‚น142.21 B
Marketcap
โ‚น1,902
Share price
1.83%
Change (1 day)
17.19%
Change (1 year)

P/E ratio for Innoviva (INVA)

P/E ratio as of December 2025 (TTM): 11.0

According to Innoviva's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.9735. At the end of 2024 the company had a P/E ratio of 46.9.

P/E ratio history for Innoviva from 2005 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202446.9706.87%
20235.8134.65%
20224.32-21.69%
20215.51-1.25%
20205.58-39.3%
20199.19106.03%
20184.46-60.37%
201711.3-42.11%
201619.5-129.53%
2015-65.9

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Onconova Therapeutics
ONTX
-0.9953-109.07%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-5.58-150.88%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.